Home ›
Organizations ›
ACCESS TO ADVANCED HEALTH INSTITUTE
ACCESS TO ADVANCED HEALTH INSTITUTE
WA · Medical Research · EIN 911608978
62
Executives Disclosed
$18.4M
Annual Revenue
$20.4M
Total Assets
3.4:1
Internal Pay Ratio
ACCESS TO ADVANCED HEALTH INSTITUTE has 62 executives with disclosed compensation. The highest-paid executive, Corey Casper (CEO, PRESIDE), received peak total compensation of $660,114. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Corey Casper | CEO, PRESIDE | $660K | $516K | 2017–2024 | 8.8x |
| Candice Decaire | CHIEF STRATE | $635K | $635K | 2022–2024 | 8.5x |
| Bassof Michael | EVP, PHILANTHROPY | $440K | $440K | 2019–2019 | 5.9x |
| Steven Reed | PRESIDENT & CEO/DIRECTOR | $422K | $341K | 2016–2018 | 5.6x |
| Casper Corey | INTERIM PRESIDENT & CEO | $412K | $412K | 2019–2019 | 5.5x |
| Jerry Kuo | CFOO, V.P. & | $400K | $396K | 2022–2024 | 5.3x |
| Reed Ph D Steven | FOUNDER, DISTINGUISHED INVESTIGATOR | $386K | $386K | 2019–2019 | 5.2x |
| Cory Casper | CHIEF SCIENTIFIC OFFICER | $344K | $344K | 2018–2018 | 4.6x |
| Anna Marie Beckmann | EVP, PRODUCT | $322K | $299K | 2016–2024 | 4.3x |
| Christopher Fox | SENIOR VP OF | $299K | $264K | 2017–2024 | 4x |
| Dan Stinchcomb | CHIEF SCIENTIFIC OFFICER | $281K | $281K | 2017–2017 | 3.8x |
| Linda Hawkins | SENIOR DR. Q | $269K | $246K | 2017–2024 | 3.6x |
| Coler Rhea | SVP, PRE-CLIN. & TRANSL. RESEARCH | $239K | $239K | 2019–2019 | 3.2x |
| Robrick Smith | DIRECTOR, IN | $239K | $215K | 2020–2024 | 3.2x |
| Parish Tanya | SVP, DRUG DISCOVERY | $226K | $226K | 2019–2019 | 3x |
| C Stephen Cordial | CFO/DIRECTOR THRU 03/18 | $223K | $0 | 2016–2018 | 3x |
| Suzan Snodgrass | DIR. FINANCE | $218K | $200K | 2023–2024 | 2.9x |
| Emily Voigt | DR. RNA PROG | $209K | $178K | 2022–2024 | 2.8x |
| Douglas Bradley | GENERAL COUNSEL/SECRETARY | $207K | $191K | 2016–2017 | 2.8x |
| Winston Wicomb | DIRECTOR, VIVARIUM THRU 05/20 | $207K | $0 | 2016–2020 | 2.8x |
| Wincomb Winston | DIR. OF VIVARIUM | $204K | $204K | 2019–2019 | 2.7x |
| Tanya Parish | SVP, DRUG DISCOVERY | $202K | $202K | 2016–2018 | 2.7x |
| Andrew Johnson | ASS. DIRECTO | $200K | $196K | 2023–2024 | 2.7x |
| Lisa McNeill | DR. MANUFACT | $196K | $175K | 2022–2024 | 2.6x |
| Darren Klemkow | DR. FACILITI | $192K | $184K | 2020–2024 | 2.6x |
| Zachary Sagawa | DR. CLINICAL | $189K | $173K | 2022–2024 | 2.5x |
| Lisa Bouchard | DR. QUALITY | $187K | $170K | 2022–2024 | 2.5x |
| Darrick Carter | VP, ADJUVANT TECHNOLOGY | $187K | $187K | 2016–2016 | 2.5x |
| Jeffrey Guderian | DIR. LABORATORY MANAGEMENT | $186K | $186K | 2020–2023 | 2.5x |
| Alan Lew | SENIOR CLINICAL TRIAL MANAGER | $186K | $186K | 2022–2022 | 2.5x |
| Fox Christopher | VP, FORMULATIONS | $183K | $183K | 2019–2019 | 2.4x |
| Neil O'Connor | PRESIDENT & COO | $183K | $183K | 2020–2020 | 2.4x |
| Richard Lautch | COO/DIRECTOR | $183K | $183K | 2017–2018 | 2.4x |
| Mary Thomson | GENERAL COUNSEL & SECRETARY | $182K | $182K | 2018–2018 | 2.4x |
| Hawkins Linda | DIR. QUALITY ASSURANCE & COMPLIANCE | $174K | $174K | 2019–2019 | 2.3x |
| Cynthia Shumate | GENERAL COUNSEL & SEC. THRU 07/20 | $173K | $173K | 2020–2020 | 2.3x |
| Kim Clary | VP, ALLIANCE MANAGEMENT | $171K | $171K | 2016–2016 | 2.3x |
| Harnik Gulati | DIR. PROJECT MANAGEMENT | $170K | $170K | 2022–2022 | 2.3x |
| Antony Christopher | VP, OPERATIONS | $170K | $170K | 2019–2019 | 2.3x |
| Damon Pang | SENIOR CORPO | $168K | $0 | 2022–2024 | 2.2x |
| Erik Iverson Llm | PRES. OF BUS & OPS/SECRETARY | $167K | $167K | 2016–2016 | 2.2x |
| Jeffery Guderian | DR. LABORATO | $166K | $166K | 2024–2024 | 2.2x |
| Joshua Odingo | DIRECTOR, CHEMISTRY | $165K | $165K | 2016–2016 | 2.2x |
| Amy Semenov | DIR. HUMAN RESOURCES | $161K | $161K | 2023–2023 | 2.1x |
| Kramer Ryan | DIR., PROCESS & PRODUCT DEV. | $161K | $161K | 2019–2019 | 2.1x |
| Smith Robrick | DIR., INFORMATION TECHNOLOGY | $159K | $159K | 2019–2019 | 2.1x |
| Lee Schoentrup | DIR., COMMUNICATIONS | $158K | $158K | 2016–2018 | 2.1x |
| Frevol Aude | ASSOC. DIRECTOR, CLINICAL OPS. | $157K | $157K | 2019–2019 | 2.1x |
| Christopher Antony | VP, OPERATIONS - EH&S OFFICER | $157K | $157K | 2017–2018 | 2.1x |
| John Argerious | ASSOCIATE DIRECTOR, BUSINESS ADMIN | $157K | $157K | 2022–2022 | 2.1x |
| Erasmus Jesse | POSTDOCTORAL FELLOW | $150K | $0 | 2019–2019 | 2x |
| Robert Kinsey | SENIOR MANAGER, FORMULATIONS | $147K | $0 | 2023–2023 | 2x |
| Erik Laursen | DIR. GMP OPERATIONS | $147K | $0 | 2020–2020 | 2x |
| Theresa Britschgi | SENIOR PROJECT MANAGER | $145K | $0 | 2023–2023 | 1.9x |
| Laursen Erik | DIRECTOR, GMP OPERATIONS | $141K | $0 | 2019–2019 | 1.9x |
| Cristina Goman | CLINICAL TRIAL MANAGER | $139K | $0 | 2023–2023 | 1.9x |
| Robert Lin | VP, FINANCE THRU 07/16 | $120K | $0 | 2016–2016 | 1.6x |
| Lautch Richard | COO | $56K | $0 | 2019–2019 | 0.7x |
| Raoul Concepcion | BOARD MEMBER | $55K | $0 | 2024–2024 | 0.7x |
| Gail Cassel | DIRECTOR | $27K | $0 | 2017–2017 | 0.4x |
| Keeley Foley | CHIEF EXICUT | $10K | $0 | 2024–2024 | 0.1x |
| Edward Hsu | BOARD MEMBER | $760 | $0 | 2024–2024 | 0x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 12 | $211K | $422K | $1.9M |
| 2017 | 14 | $220K | $373K | $2.2M |
| 2018 | 12 | $212K | $344K | $2.3M |
| 2019 | 16 | $245K | $440K | $3.2M |
| 2020 | 11 | $224K | $413K | $1.6M |
| 2022 | 17 | $247K | $660K | $4.2M |
| 2023 | 20 | $259K | $584K | $4.4M |
| 2024 | 19 | $268K | $635K | $4.0M |
Email Alerts
Get notified about ACCESS TO ADVANCED HEALTH INSTITUTE
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.